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INTRODUCTION
The study of tumours of parotid gland is a fascinating and a novel one 
but sometimes this seemingly familiar disease remains a trouble to  both the 
patient and the surgeon. There is a real threat of injuring the facial nerve, but 
with a striking change in the attitude of medical profession towards proper 
understanding  of  anatomy  of  parotid,  especially  of  facial  nerve  and  its 
intricate  relationship  to  the  gland,  the  danger  is  becoming  less  nowadays. 
Similarly thorough knowledge about various characteristics of each type of 
tumour  arising  from  parotid  and  their  response  to  various  modalities  of 
treatment is necessary for adequate management of these neoplasms.
AIM OF THE STUDY
The following are aims of our study:
 To  analyze  the  incidence  of  different  tumours  occurring  in 
parotid gland.
 To  study  the  mode  of  presentation  of  benign  and  malignant 
neoplasms.
 To  study  the  accuracy  of  FNAC  in  diagnosing  the  tumours 
preoperatively.
 To identify any common predisposing factors.
 To monitor the post operative facial nerve weakness.
HISTORICAL BACKGROUND
It is surprising to note that little was known about the parotid gland until 
the middle of seventeenth century. Interestingly, NIELS STENSON, in 1660, 
while dissecting in Amsterdam, discovered and described the duct of parotid 
gland in sheep's head which now bears his name.
The first  published reports  of  tumors  of  parotid  gland are  generally 
credited to C.G.SIEBOLD, in 1793 and I.P.SIEBOLD, in 1797. SIEBOLD's 
first operation was done in 1781.
AUGUSTE  BERNARD  published  the  important  treatise  on 
classification and about the tumours of parotid gland in 1841. BILLROTH in 
1859 published some articles describing the parotid tumours so well that  his 
intricate details could very well be used even today. The first attempt at total 
parotidectomy with preservation of nerve was made by CODREANU in 1892.
VILRAY BLAIR in 1912, SISTRUNK in  1921, ADSON in 1923 and 
BAILEY in 1941 demonstrated various methods to protect the nerves.
RADON of France did the first conservative surgery in 1934, JAMES in 
1934, BAILEY in 1935 and DAVID PATEY in 1965 in modern times.
SURGICAL ANATOMY AND PHYSIOLOGY 
DEVELOPMENT OF PAROTID GLAND
The parotid gland is derived from the ectodermal covering of maxillary 
process of the first branchial arch. At the 6th week of embryonic life, an epithelial 
bud appears near the angle of mouth in the groove that  eventually marks the 
separation  between cheek  and alveolus.  At  about  7th  week the  bud  elongates 
towards  the  ear  and  becomes  hollowed  into  a  tunnel  which  will  eventually 
become the parotid duct. The blind end of the tunnel proliferates to form the body 
of  parotid  gland.  While  acinar  cells  can  be  found  at  the  age  of  5  months, 
differentiation of the gland is incomplete until sometimes after birth. 
ANATOMY
The parotid gland is situated below the external auditory meatus and lies 
in  the  deep  hollow  behind  the  ramus  of  mandible  and  in  front  of  the 
sternocleidomastoid.
As seen from the superficial surface, the parotid gland is roughly wedge 
shaped with base above and apex behind the angle of mandible.
SURFACE BORDERS
1. Apex
2. Base or superior surface
3. Superficial surface
4. Anteromedial surface
5. Posteromedial surface
1. Anterior
2. Posterior
3. Medial
RELATIONS
The  apex  overlaps the posterior belly of the digastric and the  adjoining 
part of the carotid triangle. The cervical branch of the facial nerve  and the two 
divisions of the retromandibular veins emerge through it.
The base or superior surface forms the upper end of the gland, which is 
small and concave. It is related to:
1. The cartilaginous part of the external acoustic meatus.
2. The posterior surface of the temporomandibular joint.
3. The superficial temporal vessels.
4. The  auriculo-temporal  nerve  which  winds  round  the  mandibular
neck, embedded in the glands capsule.
The superficial surface is the largest of all surfaces. It is covered with: 
1. Skin
2. Superficial  fascia,  which  contain  facial  branches  of  the  greater
auricular  nerve,  superficial  parotid  lymph  nodes,  the  posterior 
border of platysma.
3. The parotid fascia, which is thick and adherent to the gland.
4. Few  parotid  lymph  nodes  embedded  in  the  gland.  It  extends
upwards  to  the  zygomatic  arch,  back  to  overlap  the 
stemocleidomastoid,  down  to  its  apex  posteroinferior  to  the 
mandibular angle and forwards to superficial to the masseter below 
the parotid duct.
The  anteromedial  surface  is  grooved  by  the  posterior  border  of  the 
mandibular ramus. It is related to:
1. Masseter
2. The lateral surface of the temporomandibular joint.
3. The posterior border of the ramus of the mandible.
4. The medial pterygoid.
5. The emerging branch of the facial nerve.
The  posteromedial  surface  is  mounded  to  the  mastoid  process, 
sternocleidomastoid, posterior belly of the digastric and the styloid process and its 
muscles. Thus it is related to:
1. The mastoid process with the sternomastoid and posterior belly of 
digastric.
2. The styloid process with the structures attached to it.
3. The external carotid artery enters the gland through this surface.
4. The internal carotid artery lies deep to the styloid process.
The  anterior  border  separates  the  superficial  surface  from  the 
anteromedial surface. It extends from the anterior part of the superior surface to 
the apex. The following structures emerge at this border:
1. The parotid duct.
2. Most of the terminal branches of the facial nerve.
3. Transverse facial vessels.
In addition the ACCESSORY PAROTID GLAND lies on the parotid duct 
close to its border.
The  posterior  border  separates  the  superficial  surface  from  the 
posteromedial surface. It overlaps the sternomastoid.
The  medial  border  separates  the  anteromedial  surface  from  the 
posteromedial surface. It is related to the lateral wall of the pharynx.
The superior margin of the gland extending upwards behind the TM joint 
into  the  posterior  part  of  mandibular  fossa  is  called  as  the  'GLENOID 
PROCESS'.
The anterior  margin  of  the  gland extending forwards  superficial  to  the 
masseter muscle to form the 'FACIAL PROCESS'.
The  deep  part  of  the  gland  extending  forwards  between  the  medial 
pterygoid muscle and the ramus of the mandible to form  the  'PTERYGOID 
PROCESS'.
Structures within the parotid gland
The structures within the parotid gland from medial to lateral are:
1. Artery
2. Veins
3. Facial nerve
1.  Arteries
The  external  carotid  artery  enters  the  gland  through  its  posteromedial 
surface. The maxillary artery leaves the gland through its anteromedial surface. 
The superficial temporal artery after its branch  Transverse facial branch in the 
gland ascends to leave its upper limit.
2.  Veins
The retromandibular vein is formed within the parotid gland by the union of 
the superficial temporal and maxillary veins. In the lower part of gland it divides 
into anterior and posterior divisions, which leave the lower part of the gland. The 
anterior division joins the facial vein and the posterior division unites with the 
posterior auricular vein to form the external jugular vein.
3. Facial nerve
The facial nerve leaves the stylomastoid foramen and enters the  parotid 
gland through the upper part of its posteromedial surface and divides into its five 
terminal branches. The five branches of the facial nerve are:
1. Temporal branch
2. Zygomatic branch
3. Buccal branch
4. Mandibular branch
5. Cervical branch
Within the parotid gland these three structures are placed in such a manner 
that the artery lies in the deepest plane, the vein in the middle, and the facial nerve 
in  the  superficial  plane.  Within  the  parotid  gland, the  facial  nerve  and  the 
retromandibular  vein  divide  the  gland  into  superficial  and  deep  part  by  the 
PATEY's FACIO-VENOUS PLANE.
CAPSULES OF THE PAROTID GLAND
The parotid gland is a lobulated mass surrounded by a connective  tissue 
capsule. In addition, the gland is enclosed in a dense fibrous capsule derived from 
the investing layer of deep cervical fascia.
PAROTID DUCT (STENSON DUCT)
The parotid duct is about 5cm long and 5mm in diameter, begins  by the 
confluence of two main tributaries within the anterior part  of the  gland, then 
crosses the masseter and at its anterior border turns medially at  almost at right 
angle,  traversing  the  corpus  adiposum  (Suctorial  pad  of  infants)  and  the 
buccinator.  It  then  runs  obliquely  forwards  for  a  short  distance between the 
buccinator and the oral mucosa, which serves as a  valve like mechanism and 
prevents  the  inflation  of duct during violent blowing and open upon a small 
papilla opposite the crown of upper second molar teeth.
While crossing the masseter it receives the accessory parotid duct and here 
lies  between  the  upper  and  lower  buccal  branches  of  the  facial nerve.  The 
accessory part of the gland and the transverse facial artery are above it. The buccal 
branch  of  the  mandibular  nerve,  emerging  from  beneath  the  temporalis  and 
masseter is just below the duct at the masseter's anterior border.
The wall of parotid duct is thick, with n external fibrous layer consisting 
non striated muscle and a mucosa lined by low columnar epithelium. 
VESSELS AND NERVES
The parotid arterial supply is from the external carotid artery and its branches 
in  and near  the  gland.  The  veins  drain  to  the  external  jugular  through  local 
tributaries.  The lymph vessels  end in  the  superficial  and deep cervical  lymph 
nodes.
The efferent innervation is autonomic consisting of sympathetic fibers from 
the external carotid plexus.
The parasympathetic fibers which reach it via the tympanic branch of  the 
glossopharyngeal nerve relaying in the otic ganglion and then travelling along the 
auriculotemporal  nervc. The preganglionic fibres begin in the inferior  salivary 
nucleus and passes through the 9th nerve, its tympanic branch, the tympanic plexus 
and the lesser petrosal nerve, and relay in otic ganglion. The post ganglionic fibres 
pass through the auriculotemporal nerve and reach the gland.
The parasympathetic nerves are secretomotor.
The sympathetic nerves are vasomotor.
The sensory nerves to the gland come from the auriculotemporal  nerve. 
But the parotid fascia is innervated by the sensory fibres of the greater auricular 
nerve.
PAROTID LYMPH NODES
The parotid lymph nodes partly lie in the superficial fascia and partly deep 
to the deep fascia over the parotid gland. They drain:
1. The temple
2. The side of scalp
3. The lateral surface of auricle
4. The external acoustic meatus
5. The middle ear
6. The parotid gland
7. The upper part of the cheek
8. The parts of the eyelid
9. The orbit
The efferent from these nodes pass to the upper group of deep cervical 
nodes. The deep nodes lie between the gland and the sidewall of pharynx and they 
drain:
1. The nasopharynx
2. Back of nose.
SURFACE ANATOMY
The parotid duct can be felt on the face or in the vestibule of the mouth 
more easily and rolled on the anterior border of masseter, by pressing  fingers 
backward on it (with the teeth clenched to make the muscle tense)
The  anterior  border  of  the  parotid  gland  is  represented  by  a  line 
descending from the mandibular condyle to a point 2 cm inferoposterior to  the 
angle of mandible.  Its concave upper border corresponds to a curve from  the 
mandibular condyle across the ear lobule to the mastoid process. The  posterior 
border is indicated by a straight line between the ends of anterior  and upper 
border.
The parotid duct corresponds to the middle third of a line drawn from the 
lower border of tragus to a point midway between the nasal  ala and  the upper 
labial margin.
PATHOLOGY OF PAROTID TUMOURS
In  view  of  their  relatively  undistinguished  normal  morphology,  the 
parotid  gland  give  a  surprising  variety  of  benign  and  malignant  tumours. 
There  are  many classification detailing the  different  tumours  arising in  the 
parotid  gland.  The  widely  followed  are  the  WHO classification.  The  four 
important classification are given below:
1. Foote and Frazell (1954)
2. Patey's
3. Schwartz's classification
4. International classification
I.FOOTE AND FRAZELL'S CLASSIFICATION
A. Benign parotid tumours approximately 75%:
1. Mixed parotid tumours
2. Papillary cystadenoma lymphomatosum
3. Oxyphil/acinic cell adenoma
4. Benign lymphopepithelial lesion
5. Hemangioma
6. Others.(Iipomo,neurofibroma,etc.)
B. Malignant parotid tumours approximately 25%:
1. Mucoepidermoid tumours
a. low grade
b. high grade
2. Adenocarcinoma
a. classic
b. trabecular
3. adenoid cystic carcinoma (cylindroma)
4. acinic cell carcinoma
5. Malignant mixed tumours
6. squamous cell carcinoma
7. undifferentiated
8. unclassified (melanoma,lymphoma)
9. miscellaneous
10. metastatic tumour
11. others
II. PATEY'S CLASSIFICATION:
a. Those that grow by expansion
1. Mixed parotid tumours
2. adenolymphoma
3. cysts 
b. Those that grow by infiltration:
1. recurrent mixed tumour
2. cylindromas 
3. mucoepidermoid tumours
4. carcinoma
III. SCHWARTZ'S CLASSIFICATION
a. Benign:
1. mixed parotid tumours
2. papillary cystadenoma lymphomatosum
3. oxyphil adenoma (oncocytoma)
4. Mickulicz's disease
5. asymptomatic enlargements
b. Malignant:
l. from acinar epithelium:
a. adenoid cystic carcinoma
b. acinar cell adenocarcinoma
c. anaplastic adenocarcinoma 
2. from ductal epithelium:
a. high grade
b. low grade 
3. malignant mixed tumour
4. miscellaneous lesions.
IV.  WHO CLASSIFICATION
A. EPITHELIAL TUMORS
ADENOMA
l. Pleomorphic adenoma
2. Warthin  tumour
CARCINOMA
1. Acinic cell neoplasm
2. Mucoepidermoid carcinoma
3. Adenoid cystic carcinoma
4. Adenocarcinoma
5. Squamous cell carcinoma
6. Undifferentiated carcinoma
7. Carcinoma in pleomorphic adenoma
B.  NON EPITHELIAL TUMORS
1. Haemangioma
2. Lymphangioma
3. Neurofibroma
4. Neurilemmoma
5.  Malignant lymphoma 
PATHOLOGIC FEATURES OF DIFFERENT TUMOURS
BENIGN TUMOURS
INCIDENCE : Approximately 80% of all parotid neoplasms are benign 
and 80% of the benign tumours are pleomorphic adenoma. 
1. PLEOMORPHIC ADENOMA: (mixed tumor)
The term mixed tumor was used by Minsen (1874) to stress the  dual 
origin of this type of growth from epithelial and mesenchymal elements. The 
pleomorphic  adenoma occurs  most  frequently  in  the  4th to  6th decade as  a 
painless, single, slow growing, moderately firm, movable,  smooth nodule or 
mass.
Although usually single, multiple mixed tumors have been reported. In 
the parotid gland, about 90% arise in the tail of superficial part, but about 10% 
have their origin in the deep portion.
Numerous theories have been postulated:
1. Mesenchymal
2. Branchiogenic
3. Embryonal gland anlagen
4. Adult epithelial or myoepithelial tissue
5. Histogenesis from intercalated duct
Two types of mucin have been demonstrated:
1. An epithelial type, elaborated by glandular structures.
2. A mesenchymal type, found in myxomatous areas  produced by 
the myoepithelial cells.
GROSSLY
The  pleomorphic  adenoma  is  rounded  to  bosselated  with  recurrent 
growth tend to multilobulated. Although it appears to have fibrous capsule, it 
is not truly encapsulated, a condition responsible for high rate of recurrence. 
Most tumors are 2 to 5cm in size. 
MICROSCOPIC APPEARANCE
Wide variety of patterns found
1. Epithelial cells proliferate in strands and some take on duct like
arrangements. Materials found in the duct like lumina is some 
cases resemble Colloid, and in others mucin. The former has been 
called  EPITHELIAL  MUCIN  whereas  the  latter  is
MYOEPITHELIAL MUCIN.
2. Others  cells,  probably  of  myoepithelial  origin  proliferates  in
sheets. This myoepithelial product may simulate cartilage.
3. In  parts  of  the  tumor  a  mucoid  material  is  produced  which
separates  the  cells  producing  a  myxomatous  appearance  and 
then an appearance resembling cartilage.
4. Myxoid areas occur in 90% whereas overl/3rd exhibits such an
areas as dominant feature.
5. One half contain pseudocatilage, true cartilage and rarely even
bone.
6. squamous epithelial masses are seen in 25%.
7. Pseudoadenoid  arrangements  of  epithelial  cells  resembling
adenoid cystic carcinoma in 10%.
8. Sebaceous glands or tyrosine crystals may be seen.
9. Calfication may be seen in old tumors.
MONOMORPHIC ADENOMAS
ADENOLYMPHOMA  OR  WARTHIN'S  TUMOR  OR  PAPILLARY 
CYSTADENOMA LYMPHOMATOSUM
Warthin's  tumor  is  a  benign  tumor,  arising  most  commonly  in  the 
lower portion of the gland overlying the angle of mandible. It forms 10% of all 
parotid neoplasms. Men are chiefly affected, more common between 40 to 70 
years of age. About 7% of tumors occur bilaterally. Rarely an  extraparotid 
lesion and malignant variant has been described.
HISTOGENESIS OF WARTHIN'S TUMOR
One  theory  is  that  tumor  represents  neoplastic  proliferation  of 
heterotopic salivary gland rests entrapped during growth and development in 
lymph nodes adjacent to or within the parotid gland. However because the 
amount of lymphoid tissue is far greater than that of a small lymphocyte in 
which  the  tumor  theoretically  originated.  There  is  current  support  for  this 
hypothesis  that  the  proliferating  epithelial  cells  somehow  cause  the 
accumulation of lymphoid tissue and the differentiation of IgA plasma cells.
MICROSCOPIC APPEARANCE
The  essential  components  of  this  neoplasm  are  EPITHELIAL 
PARENCHYMA  and  LYMPHOID STROMA  The parenchymatous  tissue 
is composed of tubules and dilated cystic spaces into whose lamina project 
slender  finger  like  papillary  process  giving  the  neoplasm  characteristics 
appearance. The stroma contains lymphoid tissue including lymph follicles/T 
& B lymphocytes show a normal distribution ratio.
OXYPHIL GRANULAR CELL ADENOMA OR OXYPHIL
ADENOMA OR ONCOCYTOMA
This  rare  benign  tumor  constitutes  less  than  1%  of  all  parotid 
neoplasms.  The  true  tumors  are  slow  growing  behaving  rather  like 
pleomorphic  adenoma.  Most  patients  are  between  55  and  75  years  of  age 
occurring most commonly in women.
The oncocytoma is well circumscribed, smooth surfaced rather firm. 
MICROSCOPIC FEATURE
The  cells  are  monotonous,  pink,  plump  and  polyhedral  with  nucleus 
round & centrally located. The most common arrangement of the cells is in 
broad parallel columns, acinar or tubular formation. There are no lymphoid 
cells in the true oncocytoma.
PAPILLARY CYSTADENOMA
This rare tumor consists of gland like spaces lined with tall columnar 
epithelium having eosinophilic cytoplasm. Mucin is commonly produced and 
may fill the gland like spaces.
HEMANGIOMA
This  is  the  most  common parotid  tumor  during the  first  year  of  life 
usually  appearing within the first three months. Skin hemangioma overlie the 
parotid tumor in about 40% of patients with male : female ratio of 3:1.
Histologically, the hemangioma is composed of capillary vessels lined 
by  two  or  more  layers  of  endothelial  cells  and  is  never  encapsulated  but 
infiltrates the gland, replaces the acini and leaves only the ductal elements. 
Spontaneous regression is usual and recurrence following surgery is rare.
LYMPHANGIOMA
There are three types of lymphangioma
1. simple lymphangioma
2. Cavernous lymphangioma
3. Cystic hygroma
The thin walled lymph spaces invade the parotid and adjacent tissue and 
do  not  replace  glandular  parenchyma.  The  tumor  is  soft,  fluctuant  and 
transluminant.
TUMORS OF VARIABLE MALIGNANCY
MUCOEPIDERMOID TUMOR
Since the time the tumor was described, debate has continued about its 
biological classification. This can be summarized as follows:
A. One view is  that  it  is  always  a  carcinoma whose  behavior  is 
related to its histology. Low grade or well differentiated tumors act like benign
mixed  cell  tumors,  intermediate  are  aggressive  and  high  grade  or
undifferentiated tumors metastasize early and carry a poor prognosis.
B. The  more  recent  view  is  that  behavior  is  not  related  to  its 
histological  appearance  and  apparently  benign  ones  can  eventually 
metastasize,  while  initially  aggressive  ones  can disappear  with appropriate
treatment.  For  this  reason  only  the  term  "TUMOR"  is  applied  rather
than "CARCINOMA".
About  5-10  %  of  major  salivary  gland  tumor  and  10%  of  minor 
salivary gland tumor are mucoepidermoid tumor.  Within the major salivary 
gland 90% of these arise in the parotid gland. The tumor is painless, firm, non 
tender and slow growing with rare involvement of facial nerve. There appears 
to be no sex predilection. 
MICROSCOPIC FEATURES:
It is composed of epidermoid cells mucous secreting cells and cells of 
intermediate  type.  The  presence  of  small  cysts  is  common  in  well-
differentiated  tumors.  Even  the  well  differentiated  has  the  capacity  to 
metastasize.
The  varied  cell  types  suggest  that  the  tumor  arises  from  ductal 
epithelium with marked potential for varied differentiation and metaplasia.
2.  ACINIC CELL TUMOR
This  relatively  rare  tumor  comprises  about  2-3%  of  all  parotid 
neoplasms or 10-20% of malignant parotid tumor. For every 6 cases in parotid 
gland,  there  is  one in  the  submandibular  gland and one  in  the  oral  minor 
salivary  gland.  There  is  slight  female  preponderance.  The  tumor  is  firm,  
rounded occurring most  often in  the lateral  portion or  tail  of  parotid,  well 
encapsulated  in  less  than  15%of  cases,  slow growing  but  has  tendency  to 
recur, especially when poorly encapsulated. Local recurrence occur in about 
15%  and  is  usually  multiple.  Metastasis  occur  most  frequently  to  lymph 
nodes, lungs, bone and brain.
A poor prognosis seems to be correlated with:
 size of tumor
 Involvement of deep lobe
 Amount of nuclear atypia and mitosis
 Absence of capsule
Less than 3% of patients complain of pain but facial nerve involvement 
is rare. 
The tumor most commonly occurs in the 3rd - 4th decade.
MICROSCOPIC FEATURES
Acinic  cell  carcinoma is  composed of  varying proportions  of  one  or 
more cell types
 Acinic cells
 Inter calatcd cell
 Vacuolated cells
 Non specific glandular
The cells form large lobules with little intervening stroma suggests that 
the tumor arises from pluripotent duct cells,  most  l ikely  the intercalated  or 
terminal duct cells. Various growth patterns are seen.
 Solid
 Microcystic
 Papillary - cystic
 Follicular
The  stroma  is  scanty.  The  PAS  positive  material  may  be  present, 
especially  in  microcystic  areas,  A  lymphoid stroma  is  occasionally  present 
representing  origin  in  intra  parotid  lymph  node.  Some  tumors  resemble 
adenocarcinoma of kidney.
MALIGNANT TUMORS
1.ADENOID CYSTIC CARCINOMA:( CYLINDROMA)
This constitutes about 5-10% of all  parotid gland tumors with  slight 
female predilection. Most patients are between 30-70 years of age  and peak 
incidence at 6th decade.
The tumor is slow growing of moderate to low grade malignancy but is 
widely infiltrative and poorly encapsulated. Patients with tumors complain of 
pain  in  about  40%  cases.  The  tumor  is  usually  small  (2-4cm),  firm, 
homogenous and grayish white in cross section.
MICROSCOPIC FEATURES
It  manifest  with  varying  pattern  of  small  darkly  staining  cells  with 
scanty cytoplasm. The pattern most often seen are:
1. Cribriform  pattern  is  characterized  by  nests  of  tumor  cells
with swiss cheese configuration may be noted.
2. Trabecular  pattern  is  characterized  by  elongated  tubular
structures having a central lumen.
3. Solid  pattern  consists  of  individual  unit  of  variable  size 
completely filled with cells exhibiting new lumina.
Recurrences  have  been  noted  in  60%  with  predominantly  tubular 
pattern,.90%  with  cribiriform  pattern  and  100%  with  solid  pattern.  The 
overall  salvage  rate  is  50%.  Facial  nerve  involvement  is  common  with 
invasion  of  perineural  lymphatics  readily  demonstrated.  This  finding  is 
correlated with poor prognosis.
ADENOCARCINOMA
This does not differ from the adenocarcinoma of other organ. The cells 
are  arranged in  ducts  or  tubules  and the  tumour  cells  infiltrate  the  blood, 
lymphatics and perineuarl spaces. The adenocarcinoma producing much must 
be differentiated from mucoepidermoid carcinoma. The tumor is firm, may be 
papillary or non-papillary and mucous secreting or non-mucous secreting.
The  incidence  is  3%  with  no  sex  or  age  predilection.  The  5-year 
survival rate is 40%. The prognosis depends on the degree of differentiation.
CARCINOMA IN PLEOMORPHIC ADENOMA
(MALIGNANT MIXED TUMOR)
By definition this tumor is a binary combination of benign mixed tumor 
and a malignant neoplasm, most often poorly differentiated adenocarcinoma.
It may comprise as much as 2-5% of all tumors. There appears to be 3:1 
female sex predilection with age incidence ranges from 35-85 years,  mean 
age of 60 years. This is about 10 years older than the mean age for benign 
mixed tumor.
MICROSCOPIC FEATURES
The pleomorphic adenomatous portions are in no way atypical but the 
malignant  areas  vary  considerably  from  tumor  to  tumor.  Some  exhibit 
considerable atypia. The cells are arranged in into small nests or tubules or  
sheets. Perineurial invasion and infiltration into adjacent connective tissue or 
fat are noted in 60-80% cases.
Local  recurrence have been noted in 50% the 5-year  survival  rate is 
55%. Metastses most often occur to lymph nodes, lungs or bone.
SQUAMOUS CELL CARCINOMA
Like mucoepidermoid tumors, these also originate in ductal epithelium 
and undergo squamous metaplasia.
MICROSCOPIC FEATURES
Share usual features of squamous cell carcinoma elsewhere.
UNDIFFERENTITED CARCINOMA
It consists of sheets or cords of anaplastic epithelial cells surrounded by 
varying amount of fibrous stroma.
It constitutes about 3-5% of all parotid tumors. Although it may occur 
at  any age,  it  is  most  commonly  seen  in  the  7!h or  8Ih decade with  no  sex 
predilection.
MICROSCOPIC FEATURES
It  is  so  undifferentiated  that  it  cannot  be  otherwise  classified.  It  is 
composed  of  compact  cell  masses  that  vary  in  size.  Mitosis  is  frequently 
abundant. Wide spread metastases to lung, bone and liver. The 5-year survival 
rate is 25%.
RARE TUMORS
SARCOMA
It  may  be  part  of  the  malignant  mixed  tumor  spectrum but  salivary 
glands  can  also  be  involved  in  osteogenic  and  chondrosarcoma  of  the 
mandible.
LIPOMA
This  must  be  differentiated  from  fatty  infiltration  which  is  usually 
bilateral.  It  lies  lateral  to  the  parotid  but  the  rare  tumor of  brown fat,  the 
hibernoma  can  occur  in  parapharyngeal  space.  Removal  is  uncomplicated 
unless  it  extends into the  anterior  compartment  of  face,  in  which case the  
terminal branches of facial nerve is at risk.
METASTAT1C TUMOR
The parotid lymph nodes may be involved by spread from carcinoma 
of  scalp  and  facial  skin  especially  melanoma.  Adenocarcinoma  from  the 
digestive tract or urogenital system may present as parotid gland metastases.
SALIVARY GLAND HETEROTOPIA
Heterotopic islands of salivary gland tissue have been described in  a 
number of sites in the head and neck, pituitary gland, middle & external ear, 
mastoid  bone,  thyroglossal  duct  cyst,  capsules  of  thyroid  &  parathyroid 
glands, mandible, lymph node and the sternoclavicular joint.
BASAL CELL ADENOMA
It is a monomorphic tumor  of salivary gland occurs as  circumscribed 
nodules in patient between 50-75 years of age with no sex predilection.  The 
basal cell adenoma differs from pleomorphic adenoma morphologically by the 
absence of myoepithelial cells.
MICROSCOPIC FEATURES
it has been classified into:
1. trabecular-tubular
2. Canalicular
3. Basaloid
Ultrastructural  studies  have  suggested  origin  from  the  intercalated 
duct. It may represent the benign analog of adenoid cystic carcinoma.
Sabaceous lymphadenoma, sebaceous carcinoma, sebaceous adenoma
The tumor is composed of proliferated sebaceous glands in the matrix of 
normal  appearing  lymphoid  tissue,  suggesting  its  development  from  intra 
parotid lymph node.
CLINICAL FEATURES AND DIAGNOSIS
Clinical  expressions  of  parotid  rumors  may  be  in  varied  forms. 
Symptoms may be :
 Unilateral swelling of the face, occasionally bilateral in case of
Warthin's  tumor,  slow  growing  and  rapid  increase  in  size
indicate malignancy.
 Pain which is characteristic feature of inflammatory condition.
Sometimes malignant tumors may present with pain which may
be local or referred pain in the face or ears.
 Paresthesia as a result of nerve infiltration.
 Paralysis of facial muscles as a result of infiltration by tumor of
facial nerve.
 Dysphagia  due  to  deep  lobe  involvement  casing  bulge  in  the
soft palate and parapharyngeal wall.
 Trismus  due  to  infiltration  of  masseter,  pterygoid and 
involvement of temporomandibular joint.
Features
 Cranial nerve deficits-  as adenoid cystic carcinoma can 
spread  perineurally  through  the  base  of  skull  and  involve  the 
cranial nerves.
 Chest pain, dyspnoea, hemoptysis - due to metastasis to 
lungs, commonly in adenoid cystic carcinoma.
The age of the patient is obviously important because mumps is much co 
commoner in children than in adults. Although mumps can be predominantly 
unilateral, the presentation should make one suspect a diagnosis of congenital 
sialectasis than mumps especially if it happens twice.
It is important to establish if the condition affects one gland or more 
than  one.  Tumors are  unilateral  apart  from  Warthin's  on  very  occasions. 
Sialectasis  also  usually  affects  only  one  parotid  gland  although  bilateral 
submandibular  involvement  is  sometime  seen.  Diffuse  enlargement 
(sialomegaly)  is  caused  not  only  by  sialectasis  but  also  benign 
lymphoepithelial lesions, drug allergies, and a number of systemic conditions.
If the swelling is related to eating then it is likely be due to calculous 
disease secondary to sialeclasis. No other sialomegaly is related to eating.
The duration of swelling due to calculi is variable and may last from 
under  an hour to several days. The benign tumors grow slowly although if 
bleeding occurs inside a cystic tumor, such as pleomorphic adenoma, then the 
patient  may  become  alarmed  by  a  growth  spurt.  The  malignant  tumors 
increase  in  size  fairly  rapidly  and  are  often  associated  with  facial  nerve 
weakness.
Pain  is  characteristic  feature  of  duct  obstruction  by  a  calculus  or 
infection. Benign lymphoepithelial lesion is often  uncomfortable rather than 
painful, as are allergic reactions. Adenoid cystic carcinoma typically presents 
with pain which may result in patient seeking  various disciplines associated 
with facial pain.
Systemic conditions such as myxoedema, diabetes, Cushing's, disease, 
hepatic  cirrhosis,  gout,  alcoholism  may  be  associated  with  the  painless 
sialomegaly. More recently parotomegaly as a  feature of bulimia and AIDS 
has  been reported.  Drugs  such as  thiouracil,  phenylbutazone.  Isoprenaline, 
distalgesicand high estrogen contraceptive pills can also cause sialomegaly.
Finally enquiry should be made into other symptom the  patient may 
have, because sarcoidosis and tuberculosis can enlarge a gland as can hydatid 
disease.
Character Benign Malignant
Duration Long standing Recent origin
Rate of growth Very slow More rapid
Size Large Smaller
Pain Absent (except in inflammatory) Present 25%
Tenderness Infrequent Frequent
Consistency Rubbery hard to soft Stony hard
Attachment Mobile Fixed
Lymph nodes Not involved Involved and diagnostic
Facial nerve Not involved Involved and diagnostic
Limitation  of  mandibular  movement 
due  to  invasion  of  jaw  and 
masticatory muscle 
Not present Present in
advanced cases.
Anaesthesia  of  skin  or  mucous 
membrane.
Not present May be
present
Resorption of adjacent bone Absent Maybe present
PHYSICAL EXAMINATION
INSPECTION should reveal which area is involved and whether it is 
one or more gland, local or diffuse swelling, skin involvement make one to 
suspect malignancy, as also facial nerve weakness.
PALPATION decides whether it is solid or cystic. Cystic masses may 
be  Warthin's  tumor,  cystic  pleomorphic  adenoma,  branchial  cysts,  and 
parasitic cysts. Solid tumors can be smooth or irregular but this helps little as 
to  the  diagnosis  because  pleomorphic  adenomas  are  often  irregular  and 
knobby.  Benign  tumors  are  always  mobile  and  any  fixation  should  raise  
strong suspicion of malignancy. In assessing any parotid mass one should ask 
the patient to clench his teeth so that the masseter is  contracted. This allows 
one to assess if the swelling is infact a hypertrophied masseter and it allows 
one to see whether or not the mass is inside the muscle or outside it. Complete 
examination of all the salivary glands is essential to decide whether or not 
other glands are affected. Pharynx and oral cavity examination should also be 
done.  Paraphayngeal tumors are either dumb-bell, in which case they present 
in  pharynx and also in the superficial lobe of parotid or deep lobe only, in  
which case  they present  primarily  in  the  pharynx pushing the  tonsil  and/or 
palate medially.
Clinical diagnosis of a salivary gland tumor is usually not difficult  but 
the following rarities should be kept in mind since they mimic sialomegaly:
• Hypertrophied masseter
• Winged mandible (in the first arch syndrome)
• Dental cysts
• Branchial cysts
• Myxoma of the masseter
• Neuroma of the facial nerve
• Facial vein thrombosis
• Temporal artery aneurysm
• Lipoma
• Lymphangioma
• Mandibular tumor
• Mastoiditis
• Lymphadenitis of pre-auricular node
• Sebaceous cyst
INVESTIGATIONS
• ROUTINE INVESTIGATIONS
• SPECIAL INVESTIGATIONS
ROUTINE INVESTIGATION 
1. To assess the patient for surgery.
2. To exclude other conditions.
3. As a base line investigation for other modalities of treatment like 
chemo/radiotherapy.
SPECIAL INVESTIGATIONS
1. To locate the tumor
2. To exclude extra-parotid mass
3. To confirm diagnosis.
LABORATORY TESTS
1. Diabetes
2. Myxoedema
3. Cushing's disease
4. Rheumatoid  factor  and  hyper  gamma  globulinemia  are
often found in Sjogren's disease
5. Uric acid levels will be raised in gout.
6. If sarcoid is suspected, a Kveim's test is required.
7. In all cases a full blood count and ESR should be done.
8. Salivary  flow  rates  will  be  less  than  0.5ml/min  in  Sjogren's 
disease.
9. The Schrimer's test also show a decrease in tearing (<5mm in 5 
min)
RADIOLOGY:
Plain film radiology
a. Antero-posterior (normal and soft tissue exposure)
b. Tangential
c. Lateral
d. Lateral-oblique  view  are  useful  for  showing  calculi  and  soft 
tissue swelling.
Sialography
Tumors produce a mass effect.
Angiography
This  is  some  times  required  in  the  investigation  of  tumors  of  the 
parapharyngeal  space  in  order  to  differentiate  salivary  gland  tumors  from 
chemodectoma  of  carotid  or  a  nerve  sheath  tumor  both  of  which  have  a 
characteristic tumor circulation.
CT & MRI
For parotid, they are the most helpful imaging techniques. They will  
confirm that the mass being investigated is indeed intrinsic to the gland. They 
accurately  image  the  borders  of  the  tumors  and  show  where  it  is  well 
circumscribed and benign or diffuse invasive and malignant. In addition they 
show the relationship of the tumors to other anatomic structures which  help 
with the planning of subsequent surgery.
MRI can be formulated in both axial and coronal planes  giving even 
better anatomical information. When carefully preformed and analyzed, MRI 
can provide information about the facial nerve and its anatomical relationship 
to the tumors.
Contrast  enhanced studies  may allow the  discrimination  between the 
gland and the metastatic lymph node.
ULTRASONOGRAPHY
It helps to differentiate between the solid and cystic lesions.
FNAC (Fine needle aspiration cytology)
Evidence suggest that provided the needle gauge does not exceed 18G, 
there  is  no risk of  seedling viable tumor cells.  Although advocates  of  this 
technique claim high accuracy and specificity, there is inevitably a high risk of 
sampling errors.
Open biopsy
Open surgical  biopsy  of  intrinsic  neoplasm of  parotid  is  absolutely 
contraindicated. At least 75% of all parotid neoplasm will prove to be benign 
pleomorphic adenoma. This tumor which is only poorly encapsulated is very 
tense and if  an incision is  made into its contents,  the tumor burst  into the  
surrounding tissue planes and it  is  impossible to eradicate the microscopic  
spillage of tumor cells. If this happens the patient will develop multiple local  
recurrences over many years unless they are subjected to radical postoperative 
radiotherapy which is best avoided in the management of benign disease.
Clearly  if  there  is  skin  infiltration  or  ulceration,  an  open  biopsy  is 
essential to establish in  pre-operative diagnosis upon which to plan surgery.
Neither  should  a  Para  pharyngeal  mass  be  biopsied  through  the 
pharynx. If the mass is chemodectoma, the bleeding will be uncontrollable and 
if it is a salivary gland tumor, recurrence will be unacceptable.
Excision biopsy is indicated if there is a parotid mass, FNAC positive 
or equivocal, suspicion of malignancy/mixed tumor.
If percutaneous biopsy technique is performed, the biopsy track should 
be included in any subsequent excision.
SCANNING TECHNIQUES
The  early  hopes  of  the  salivary  gland  scanning  with  Tc  99m 
pertecnetate have not been fulfilled. The finding that all the tumors were cold 
apart  from Warthin's  has  not  been  substantiated  in  the  long  term and  the  
technique is accompanied by an unacceptabty large number of false positive 
and false negative results.
TREATMENT
BENIGN TUMORS
The treatment of benign tumor of parotid has passed through several 
phases during the past 30 years.  Enucleation carried a high recurrence rate 
and so it  was followed by enucleation and post  operative irradiation.  This 
policy was often unacceptable in the young who were not only given a long 
time for potential and undoubted recurrences but the risk of radiation induced 
cancer was added. Recuurence rate were much lower in those series in which 
enucleation  meant  not  merely  extra  capsular  removal  of  the  tumor,  but 
removal of mass together with a good cuff of normal parotid tissue.
Since  a  proportion  of  facial  nerve  weakness  was  due  to  these 
techniques  especially  extra  capsular  enucleation as  well  as  the  other  risks,  
total superficial parotidectomy was next advocated. This was very successful 
in terms of prevention of recurrence and the nerve was safe in the hands of 
skilled operator because the first step in the operation is identification of the 
facial nerve and its two main branches. It became evident, however that the  
procedure was too often extensive e.g. removal of the upper portion of the 
parotid gland for a small tumor at the ear lobe seems unnecessary. So some 
surgeons perform a hemisuperficial parotidectomy (i.e. all the parotid tissue 
lateral to one main branch either upper or lower of the nerve.)
If the tumor involves deep lobe, it is treated by total parotidectomy with 
the preservation of the nerve.
MALIGNANT TUMORS
If the tumor is malignant, total parotidectomy with the preservation of 
the nerve is  indicated,  though it  is  a piece meal procedure.  Such cases of 
malignant parotid tumors arc followed by RT. The involvement of the branch 
of the nerve requires its removal. In young patients nerve graft should be used 
to replace the resected nerve segment in the hope of avoiding  the long term 
sequelae of facial nerve palsy. In the event of invasion of nerve by the tumor, 
any  proximal  extension  of  the  malignancy  to  the  base  of  skull  should  be 
evaluated and in some cases,  resection of the nerve to clear margin in the  
stylomastoid foramen or in the facial canal may improve survival. If the facial 
nerve is not involved by the malignancy but the preservation of nerve would 
result  in  gross  disruption  of  the  tumor,  the  nerve  should  be  removed  and 
replaced with the nerve graft.
For adenoid cystic carcinoma, supra radical surgery is not advocated. 
This tumor although probably fatal in the long is compatible with a useful 10 
year  survival  rate.  It  is  difficult  therefore  to  justify  extensive  mutilating 
surgery  without  offering  a  cure.  Adenoid  cystic  carcinoma  whose 
macroscopic  margin  remain  within  the  parotid  are  treated  by  total 
parotidectomy.  For  more  extensive  tumors  radical  dissection  with  as  wide 
margin as is anatomically appropriate while being compatible with reasonable 
rehabilitation followed by radical RT will ensure the local control  of tumor. 
The RT field should include the skull base in order to control the perineural 
tumor extension.
TREATMENT OF THE NECK
The treatment of the neck in patients with malignant disease depends 
on the histological type and the grade of the tumor and its risk of metastatic 
disease or the presence of metastatic disease itself. Node positive  necks are 
treated by the appropriate neck dissection. RND if there is  involvement of 
sternocleidomastoid  muscle  or  jugular  vein  or  modified  or  selective  neck 
dissection  depending  on  the  site  of  metastasis.  Although  elective  or 
prophylactic  neck dissection  are  not  as  frequently  necessary  as  in  mucosal 
malignancy,  they  are  indicated  in  high  grade  mucoepidermoid  carcinoma, 
squamous cell carcinoma and high grade adenocarcinoma.
COMPLICATIONS OF SURGERY AND THEIR
MANAGEMENT
The two most important complications are;
1. Facial nerve paralysis
2. Frey's syndrome
The less common complications include
1. Bleeding and hematoma formation
2. Flap necrosis
3. Salivary fistula
4. Amputation neuroma of divided great auricular nerve
1.  FACIAL NERVE PARALYSIS
Partial weakness of the facial muscles is quite common and is recovered 
if the facial nerve is identified and preserved at operation.  There are various 
methods of identifying and preserving the facial nerve intraoperatively which 
prove useful to minimize the post operative weakness.
Methods available to prevent facial nerve injury
• lntravital  staining  of  the  parotid  gland  with  2-5%
methylene blue solution.
• Neurophysiological  monitoring  of  facial  nerve  during
parotid surgery using two different 2 channel EMG units.
• Familiarity  with  the  common  variations  in  the  facial  nerve
anatomy.
Management
In transient weakness with no obvious injury-Reassurance.
In cases where division has occurred, facial nerve graft/suturing should 
be done. For practical purpose, a graft is indicated if the tension between the 
stumps is such as to break a 10% nylon suture when an attempt  is made to 
anastamoze the severed ends. This  ten rule  serve as guide. Grafting can be 
done using either greater auricular / sural nerve.
The principles to be observed in nerve grafting
• The  best  suit  graft  is  the  greater  auricular  nerve.  It  is  easily 
accessible, upto 8cm can be removed, it has two branches of  suitable 
diameter to anastamoze to the upper and lower division
• There should no tension at the anastamosis
• No scar  tissue  should  intrude  at  the  anastamosis  and  so  the 
sheath should be cut back and only a minimal number of sutures used.
• The  use  of  operating  microscope  is  advisable  to  allow  inter-
fascicular repair.
Other technique involve anastamosing the proximal hypoglossal nerve 
to the distal branches of the seventh nerve. Most recently, free tissue transfers 
of the gracilis muscles has been successfully used.
Crossed nerve grafts, bringing fibres from the normal side of the "face 
to the paralysed side.
2.  FREY'S SYNDROME
Subjective gustatory sweating and flushing of the face,which appear 
following  parotidectomy,  following  secretory  stimulation  of  salivation.  It 
manifests between 3months to 2 years after surgery.
The condition follows surgery in the region of parotid gland,  but may 
follow accidental injury to parotid. It is thought that following  injury to the 
auriculotemporal nerve, post ganglionic parasympathetic fibres from the otic 
ganglion  get  united  to  the  sympathetic  nerve  from  the  superior  cervical 
ganglion destined to supply the vessels and sweat glands of the skin .
Management
• Reassurance
• Antiperspirants
• Surgery in <10% to interrupt the parasympathetic reflex arc and
is  best  done  by  turning  back  the  ear  drum  and  dividing  the
Jacobson's nerve which runs over the promontory of middle ear
(tympanic neurectomy)
3. BLEEDING  is rare,  and is usually venous from the retroniandibular 
vein and can be easily controlled.
4. NECROSIS OF SKIN has been noted in the elderly at the junction of
the posterior  extension and the main pre-auricular incision.  The best 
way to avoid this complication is to ensure that the two incisions meet 
at 90° angle.
5. Development  of  AMPUTATION NEUROMA  of  the  divided grater 
auricular nerve.
6. SALIVARY LEAK  is a very common complication that will mostly
heal spontaneously except a few which will need exploration.
ROLE OF RADIOTHERAPY
Complete  resection  of  tumor,  even  when the  extirpation  is  radical, 
may not be possible because some tumors like adenoid cystic carcinoma tends 
to infiltrate perineural space and some tumors extend for a distance from the 
apparently encapsulated tumor. Cancer clearance may not be adequate because 
of the conservative surgery with preservation of facial nerve, where there is 
nerve  infiltration  is  widely  followed.  All  these  factors  resulted  in  a  local 
recurrence of 24-54%. The post operative RT with 5000-7000 rad resulted in 
decline of recurrence to 14%.
All the factors favored the post operative radiation an essential adjunct 
to  surgery,  as  radiotherapy can take care  of  the  residual  malignant  disease 
which is minimal or microscopic and often unrecognized.
The  indications  for  radiotherapy  are  the  following:  (TAPEY  et  al 
M.D.Anderson Hospital).
• Recurrence disease after primary surgical treatment.
• Unresectable tumors.
• Irradiation after excision with following situation.
1. After parotidectomy for low grade tumors when the  surgical margins 
are considered questionable or inadequate.
2. After parotidectomy for high grade tumors.
3. After complete removal of recurrent tumors of all degree of malignancy.
The  radiation  dose  is  usually  5500-6000  rads  in  6weeks  duration, 
usually treatment is started 10 days after surgery provided the skin is intact  
and no nerve graft  has been done. If  nerve graft has been done, the RT is 
deferred till the recovery of the muscles unless there is obvious recurrence.  
Radon  seeds,  radium  needle  can  be  used  as  interstitial  irradiation. 
Preoperative RT in the doses of 1200-3500 rads is very helpful to reduce the 
tumor size in radiosensitive tumors, namely adenoid cystic tumor and acinic 
cell tumor.
The prognosis depends on:
• Histological type
• Facial  nerve  involvement,  patients  presenting  with
facial nerve palsy have a poor prognosis.
• Lymph nodal involvement has a poor prognosis.
The 5 - year survical rates for different tumors are:
1. malignant mixed tumor 55%
2. low grade mucoepidermoid carcinoma 96%
3. high grade mucoepidermoid carcinoma 14%
4. adenoid cell carcinoma 40%
5. squamous cell carcinoma 36%
6. acinic cell carcinoma 82%
7. solid adenocarcinoma 48%
8. undifferentiated tumor 24%
ROLE OF CHEMOTHERAPY
In  occasions,  methotrexate  or  5  FU  may  produce  regression.  Such 
treatment  is  often  disappointing  and  serves  late  palliation.  .  Perfusion  of 
advanced cases with cyclophosphamide administrated by retrograde catheter in 
the superficial temporal artery has produced marked regression in few tumors.
MATERIALS AND METHODS
Our study conducted at Kilpauk Medical College and Hospital (KMCH) 
during the period from September 2004 to September 2006,  included those 
patients  who  attended  the  General  Surgical  clinics  for  the  first  time  with 
complaints of parotid swelling. The selection of the patients has been done at 
random included both the sexes and all age groups.
These patients were subjected to thorough clinical examination. All the 
basic  investigations  necessary  for  anaesthetic  assessment  and  specific 
investigation for confirming the diagnosis namely FNAC were done. CT scan 
was also done for appropriate patients. A review of 36 patients was done. Out 
of 36 patients 19 were male and 17 were female. A thorough analysis of the 
incidence rates, (according to age & sex), the symptomatology, pathology, and 
treatment adopted was done.
OBSERVATION
An analysis of 36 cases of parotid neoplasm was done. Out of 36 cases 
included in  the  study,  24  cases  were  pleomorphic  adenoma,  4  cases  were 
mucoepidermoid  carcinoma,  4  were  adenocarcinoma,  1  case  was  adenoid 
cystic carcinoma, 1 case was malignant mixed tumor and 2 other cases noted 
Incidence rate of various types tumor
Tumor Present  KMCH study %
BENIGN:
Mixed tumors 24 96
Warthin's - -
Others 1 4
TOTAL 25 cases
MALIGNANT:
Mucoepidermoid 4 36.3
Adenocarcinoma 4 36.3
Acinic cell tumor - -
Adenoid cystic carcinoma 1 9
Squamous cell carcinoma - -
Malignant mixed tumor 1 9
Undifferentiated - -
Others 1 9
TOTAL 11 cases
BENIGN TUMORS
Out of the 25 benign tumors, 24 were pleomorphic adenoma and 1 case 
was non -specific lymphadenitis in our study.
Of the 24 cases of pleomorphic adenoma, 13 were male patients amd 
11 were female patients, 13 patients had tumor in from the right parotid and 
11 patients had tumors from the left parotid.
No  patient  had  bilateral  tumors.  Obviously  there  is  no  sex  or  side 
predilection.
AGE AND SEX INCIDENCE
The age wise and sex wise distribution of patients with benign parotid 
tumors is as follows:
Age Male % Female % Total %
0-10 - - - - -
11-20 - - - - -
21-30 - - 1 4 1 4
31-40 5 20 3 12 8 32
41-50 6 24 4 16 10 40
51-60 2 8 3 12 5 20
>60 - - 1 4 1 4
TOTAL 13 12 25
Males = 13/25 = 52% Females = 12/25 = 45%
The maximum number of patients occurred in the age group 41-50, for 
all  patients  FNAC  had  done  preoperatively  and  all  the  reports  were 
pleomorphic adenoma, which was later confirmed by surgery that  24  cases 
were pleomorphic adenoma except one which was turned out to be non-specific 
lymphadenitis.
PRESENTING SYMPTOMS
The presenting symptom of the  patients  with pleomorphic  adenoma 
was swelling in the parotid region. 3 patients had associated pain. There was 
no  skin  involvement  and  fixity  to  deep  structures.  The  presenting 
symptomatology was as follows:
Swelling 25/25 100%
Swelling& pain 3/25 12
Swelling with facial nerve weakness 0 _
Swelling & neck nodes 0 -
Involvement of skin 0 -
DURATION OF SYMPTOMS
The majority of patients had symptoms for more than 1 year. A patient 
had symptom for about 11 years.
Duration No of patients %
< 1 year 1 4
For 1 year 3 12
For 2 years 5 20
For 3 years 8 32
For 4 years 4 16
For 5 years 2 8
5-10 years 1 4
>10 years 1 4
SURGERY AND ITS COMPLICATIONS
Surgery- SCP 25/25 100%
Facial nerve weakness
1.Post op
2.Recovered
3.Persistent
4/25 
3/4 
1/4
25%
Frey's syndrome - -
Fistula 2 8%
Flap necrosis 1 4%
Wound infection 1 4%
MALIGNANT TUMORS
Out of the 36 cases, 11 cases were malignant parotid tumors. Of this 11 
cases,  4  were  mucoepidermoid  carcinoma,  4  were  adenocarcinoma,  1  was 
adenoid cystic carcinoma, 1 was malignant mixed tumor and 1 was malignant 
clear cell hidradenoma. Of these 11 cases, 6 cases were male patients and 5 
were female patients. 6 patients had tumors in the right parotid and 5 patients 
had tumors in the left parotid.  No patients had bilateral  tumors. Obviously, 
like in benign parotid tumors, there is no sex or side predilection.
AGE AND SEX INCIDENCE
The age wise distribution of the patients with malignant parotid tumors 
were as follows:
Age Male % Female % Total %
0-10 - - - - -
11-20 - - - - - -
21-30 - - 1 9 1 9
31-40 1 9 - - 1 9
41-50 2 18 - - 2 18
51-60 1 9 1 9 2 18
61-70 2 18 2 18 4 32
>70 - - 1 9 1 9
TOTAL 6 5
Male - 6/11 =  55%
Female - 5/11  =   45%
PRESENTING SYMPTOMS
The  presenting  symptomatology  of  malignant  parotid  tumor  was  as 
follows:
Swelling 11/l1 100%
Swelling & pain 4/11 36%
Swelling with facial nerve weakness 4/11 36%
Swelling with skin involvement 3/11 27%
DURATION OF SYMPTOMS
The majority of patients had symptoms <6 months. The duration of 
symptoms in malignant parotid tumors was a follows:
Duration No of Patients %
< 2 months 1 9
2-4months 4 32
4-6 months 5 45
> 6 months 1 9
SIGNS
All the malignant parotid swellings were hard in consistency, 3 patients 
had skin involvement, 5 patients had fixity to deeper structures and 4 patients 
had neck nodes and one patient with mucoepidermoid carcinoma had distant 
metastases in the lung.
SIGNS NO OF PATIENTS %
Skin involvement 3/11 27
Hard consistency 11/11 100
Fixity 5/11 45
Neck nodes 4/1 1 32
Distant metastases 1/11 9
FNAC were done for all the patients, it was reported mucoepidermoid 
carcinoma in 3 cases, adenocarcinoma in 4 cases, adenoid cystic carcinoma in 
1 case, malignant mixed tumor in 1 case and these were confirmed by surgery. 
There was a histologic surprise that FNAC report as pleomorphic carcinoma 
turned out to be mucoepidermoid carcinoma in HPE report.
SURGERY AND ITS COMPLICATIONS
Surgery
1. TCP
2. TRP 
7/11 
4/11
63%
36%
Facial nerve weakness
1. Post op 
2. Recovered 
3. Persistent
6/11
0/11
6/6
54%
100%
Frey's syndrome - -
Fistula 2 18
Flap necrosis 1 9
Wound infection 1 9
DISSCUSSION
A thorough analysis of the 36 cases of tumors occurring in the parotid 
gland in the following aspects was made.
INCIDENCE
1. According to type of tumors.
2. According to age, sex and side in
• Benign parotid tumors
• Malignant parotid tumors.
II. PRESENTING SYMPTOMATOLOGY
• Benign parotid tumors
• Malignant parotid tumors.
III. DURATION OF SYMPTOMS
• Benign parotid tumors 
• Malignant parotid tumors.
IV. ROLE OF FNAC
• Benign parotid tumors 
• Malignant parotid tumors.
V.TREATMENT AND ITS COMPLICATIONS
• Benign parotid tumors 
• Malignant parotid tumors.
I. INCIDENCE
1. According to type of tumors
The  majority  of  cases  occurring  in  the  parotid  glands  were  the 
pleomorphic adenoma. Literature suggests that 80 % of the tumors occurring 
in the parotid gland are pleomoiphic adenoma. In the study conducted by the 
Mayo's clinic, 73% of the tumors were  pleomorphic adenoma. In our study 
conducted at KMCH, the incidence of pleomorphic adenoma was 96% of all 
benign parotid tumors and 66.66% of all parotid neoplasm.
COMPARISON OF INCIDENCE RATE WITH MAYO's CLINIC
Tumor Mayoclinic 
1940-1970
% Present
MCH 
Study
%
BENIGN
Mixed tumors 824 73 24 96
Warthin's 293 26 - -
Others 15 1 1 4
TOTAL 1132 25
MALIGNANT: Mayoclinic 1940-1970 %
Present
KMCH 
Study
%
Mucoepidermoid 62 27 4 36.3
Adenocarcinoma 54 24 4 36.3
Acinic cell tumor 34 15 - -
Adenoid cystic carcinoma 28 12 1 9
Squamous cell carcinoma 22 10 - -
Malignant mixed tumor 15 6 1 9
Undifferentiated 11 5 - -
Others 2 1 1 9
TOTAL 229 11
2. Acrcrding to age, sex and side in
• Benign parotid tumors
Most  of  the benign parotid  tumors  were  above the  age of 40  years. 
More number of patients occurred in the age group 41- 50 years than in any 
other  groups.  Hence  in  our  study  ,  the  pleomorphic  adenoma  of  parotid 
tumors is commoner in the age group between 41-50. this figure correlates 
with the statistics given in the literature  (Bailey and love, Short practice of 
surgery) which gives a mean age of occurrence of pleomorphic adenoma is 42 
years.
Literature suggests that there is equal sex and side incidence for both 
benign and malignant parotid neoplasm. In our study too there  was an equal 
sex incidence.
COMPARISON OF SEX INCIDENCE WITH
VARIOUS STUDIES
Study Male Female Male: Female
Bottner 10 15 0.6:1
Fray 11 14 0.7:1
Mofarland 184 212 0.8:1
Willis 16 34 0.4:1
Willis & Wilson 30 26 1.15:1
Present study 19 17 1.11:1
• Malignant parotid tumors
Majority  of  the  patients  were  above  the  age  group  of  50  years. 
Literature suggests that there is equal sex and side incidence for both benign  
and malignant  parotid  neoplasm.  In  our  study  too  there  was  an  equal  sex 
incidence.
II. PRESENTING SYMPTOMATOLOGY
•   Benign parotid tumors
All the benign neoplasm of the parotid gland Presented with swelling 
in the parotid region, 3 patients had pain over the  swelling. No patient had 
facial nerve weakness or neck node or involvement of skin.
Symptoms Our Study % Wong et al
Swelling 25/25 100% 100%
Swelling & Pain 3/25 12% 5%
Swelling  with  facial  nerve 
weakness
0 - 5%
Swelling & neck nodes 0 - -
Involvement of skin 0 - -
In study conducted by Wong et. al, (Hong Kong) which was published 
in  the journal  of  Royal  college of  Surgeons,  Edinburgh.  The percentage  of 
patients with benign neoplasm with facial nerve weakness was 5%; with pain 
was 5% and no neck nodes or skin involvement.
•   Malignant parotid tumors
The symptomatology of patients with malignant parotid tumors in our 
study  was  as  follows;  4  patients  with  pain,  4  patients  with  facial  nerve 
wakness,3 patients with skin involvement,  5 patients with fixity, 4 patients 
with neck nodes and 1 patient with distant metastases.
Our study % Wong et al
Swelling alone 3/11 27.2 32.
Swelling & pain 4/11 36.3 21
Swelling with facial nerve weakness 4/11 36.3 18
Skin involvement 3/11 27.2 15
Hard consistency 11/11 100 88
Fixity 5/11 45.4 28
Neck nodes 4/11 36.3 40
Distant metastases 1/11 9 11
III. DURATION OF SYMPTOMS
• Benign parotid tumors
The majority of patients had symptoms for more than 1 year. A patient 
had symptom for about 11 years.
Malignant Parotid tumors
The majority of patients had symptoms <6 months.
Duration Our Study % Mayo's clinic
1 week - 1 year 12/36 33.33% 33%
1 year - 4 year 20/36 55.55% 33%
>4 year 4/36 11.11% 33%
IV TREATMENT AND ITS COMPLICATIONS
•   Benign parotid tumors
Out of 25 patients with benign parotid tumors, all the 25 patients had 
undergone superficial parotidectomy. 4 patients had facial nerve weakness, 3 
patients  completely  recovered,  1  had persistent  weakness  and  was  advised 
physiotherapy. No patient had Frey's syndrome. Two patients salivary leak 
and were advised only regular dressing, 1 patient had wound infection, and 1 
patient had flap necrosis
Out study %
Surgery - SCP 25/25 100%
Facial nerve weakness
♦Post op
♦Recovered 4/25 16%
Persistent 1/4 25%
Frey's syndrome - -
Fistula 2/25 8%
Flap necrosis 1 4%
Wound infection 1 4%
• Malignant parotid tumors
Out  of  11 patients  with malignant  parotid  tumors,  7  had undergone 
total  conservative  parotidectomy  and  4  had  undergone  total  radical 
parotidectomy. Out of  these  6 patients  had facial  nerve palsy and  none of 
them recovered. No one had Frey's syndrome. 2 patients developed leak and 
managed  conservatively.  1  patient  had  flap  necrosis  and  1  had  wound 
infection.
STATISTICAL ANALYSIS
The FNAC is done in all the cases before surgery & HPE after surgery 
& the results were analysed.
FNAC Correct Diagnosis Wrong Diagnosis Total
Positive 3 4 ( a ) 2(b) 36(a+b)
Negative 0© 36(d) 36(c+d)
Sensitivity: a/a+cx100 = 34/34x100 =  100%
Specificity: d/b+dx100 = 36/38x100 = 94.7%
Positive predictive value: a/a+bxl00 = 34/36x100 = 94.44%
Negative predictive value: d/c+dxl00 = 36/36x100 = 100%
False negative %: c/a+cxl00 = 0/34x100 = 0%
False positive%: b/b+dxl00 = 2/38x100 = 5.2%
The significance of difference in mean of the results between FNAC & 
HPE is:
P    = 0.0003 (by t test). This indicates the value is significant.
Even though the sample size is very small, the above statistical analysis 
shows  that  FNAC  is  a  good  diagnostic  tool  in  parotid  neoplasms  pre-
operatively.
CONCLUSION
• Parotid tumors are not an uncommon entity.
• The most common presentation of parotid tumors is painless swelling. 
Hence any solitary swelling in the parotid gland must be considered as 
tumor until proved otherwise.
• The most common age group to be involved is between 40 - 50 years.
• There is no sex or side predilection.
• There are no definite predisposing factors for parotid tumors.
• The most  common tumor  occurring  in  parotid  gland is  pleomorphic 
adenoma.  The  most  common  malignant  parotid  tumors  are 
mucoepidermoid  carcinoma  and  adenocarcinoma.The  benign  parotid 
tumor,  pleomorphic  adenoma  present  as  painless  swelling  with  no 
evidence  of  facial  nerve  weakness  and  the  duration  of  symptoms  is 
usually more than one year.
• Clinical  signs such as hard consistency, fixity,  facial  nerve palsy  are 
seen most commonly in parotid tumors and hence these features can be 
used as diagnostic criteria preoperatively.
• FNAC is very effective in the pre operative diagnosis of parotid tumors 
and it has no complications.
• Post operative facial nerve weakness occurred in 16% with in 25% cases 
in our study.
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PROFORMA FOR PAROTID TUMORS
NAME: AGE/SEX: IP.NO:
WARD: D.O.A.: D.O.D:
PRESENTING COMPLAINTS :
SWELLING AROUND THE EAR : +/-
PAIN
WATERY DISCHARGE
FEVER
TEAR FROM EYELID/DROOLING OF SALIVA
DEVIATION OF ANGLE OF MOUTH
LOSS OF ASYMMETRY OF FACE
COUGH/HEMOPTYSIS/DYSPNOEA/CHEST PAIN    ,
BONEPAIN/FRACTURE/SWELLING FROM BONE
FOCAL NEUROLOGICAL DEFICIT
LOSS OF WEIGHT/APPETIT
PAST H/O :
H/O RADIATION
PERSONAL H/O :
ALCOHOL/ SMOKING
GENERAL EXAMINATION :
BUILD/NUTRITION
PALLOR/ICTERUS/CYANOSIS/CLUBBING/LN/EDEMA
FACIES
LOCAL EXAMINATION :
NUMBER :
SITE :
SIZE :
SHAPE:
SURFACE:
SKIN :
WARMTH/NOT , TENDER/NOT
CONSISTENCY : SOFT/CYSTIC/FIRM/HARD/VARIABLE
MOBILE WITH/WITHOUT CLENCHING THE TEETH/FIXED
BIMANUAL PALPATION OF GLAND :
MASTER CHART
S.
No. Name
Age / 
Sex IP.No. Swelling Pain
Facial 
Palsy Duration Side FNAC Node Surgery
Post-op 
Palsy Recovery
HPE 
Report
1. Srinivasan 36/M 838089 Yes - - 1 yr Left PA - SCP Yes Yes PA
2. Yuvaraj 42/M 843434 Yes - - 3 yrs Left PA - SCP - - PA
3. Raman 32/M 845777 Yes - - 3 months Right MET - TP Yes Persist MET
4. Mani 45/M 843672 Yes - - 3 yrs Right PA - SCP - - PA
5. Kalivaradhan 35/M 850169 Yes - - 3 yrs Left PA - SCP - - PA
6. Devaki 67/F 848678 Yes Yes Yes 2 months Left Adeno - TRP Yes Persist Adeno
7. Ramadass 48/M 847920 Yes - - 3 yrs Right PA - SCP - - PA
8. Jayaraman 62/M 817430 Yes Yes - 3 months Right Adeno - TP - - Adeno
9. Periyasamy 55/M 847638 Yes - - 4 yrs Right PA - SCP Yes Yes PA
10. Syed 38/M 849364 Yes - - 2 yrs Left PA - SCP - - PA
11. Vilashini 21/F 841283 Yes - - 11months Left PA - SCP - - PA
12. Malakodi 40/F 846183 Yes - - 5 yrs Right PA - SCP - - PA
13. Shanmugam 39/M 846217 Yes - - 2 yrs Right PA - SCP - - PA
14. Thilagam 53/F 845054 Yes - - 1 yr Right MET - TP Yes Yes MET
15. Hariprasad 49/M 816557 Yes Yes - 5 yrs Right PA - SCP - - PA
16. Jayanthi 38/F 862514 Yes - - 2 yrs Left PA - SCP - - Non 
specific 
lymph 
adenitis
17. Shanthi 52/F 820072 Yes - - 4 yrs Right PA - SCP - - PA
18. Elumalai 48/M 842051 Yes - Yes 5 mnths Left Adenoid - TRP - - Adenoid
19. Kuppayi 41/F 842110 Yes - - 3 yrs Right PA - SCP - - PA
20. Solai 55/M 833420 Yes Yes Yes 3 months Right MMP Upper TRP Yes Persist MMT
S.
No. Name
Age / 
Sex IP.No. Swelling Pain
Facial 
Palsy Duration Side FNAC Node Surgery
Post-op 
Palsy Recovery
HPE 
Report
deep
21. Rajeswari 36/F 830240 Yes - - 4 yrs Left PA - SCP - - PA
22. Kaliammal 28/F 826516 Yes - - 5mths Left MET - TP - - MET
23. Rani 32/F 842080 Yes - - 1 yr Left PA - SCP - - PA
24. Sivaraman 43/M 826430 Yes - - 3 mths Left Adeno Upper 
Deep
TP - - Adeno
25. Saleem 44/M 820140 Yes - - 2 yrs Right PA - SCP - - PA
26. Raman 36/M 827509 Yes - - 1½ yrs Left PA - SCP - - PA
27. Kasthuri 57/F 836408 Yes - - 4 yrs Right PA - SCP - - PA
28. Sarojammal 71/F 834308 Yes - Yes 5 mths Right Adeno Upper 
Deep
TRP Yes Persist Adeno
29. Ramani 48/F 821208 Yes - - 3 yrs Left PA - SCP - - PA
30. Shantha 53/F 835108 Yes Yes - 3 yrs Right PA - SCP - - PA
31. Saraswathi 61/F 832560 Yes Yes - 6 mths Left Acinic Upper 
Deep
TP Yes Persist Maligna
nt clear 
cell 
hidrade
noma
32. Krishnan 41/M 823450 Yes - - 3 yrs Right PA - SCP - - PA
33. Ragavan 68/M 823976 Yes - - 5 mths Right MET - TP - - MET
34. Pushpa 47/F 840068 Yes - - 3 yrs Left PA - SCP - - PA
35. Savithri 66/F 841116 Yes Yes - 11 yrs Right PA - SCP Yes Persist PA
36. Narayanan 58/M 854108 Yes - - 8 yrs Left PA - SCP - - PA
